Scott Michael Gilbert MD

Urology•Tampa, FL

Surgical Oncology

Senior Member, Urologic Oncology, H. Lee Moffitt Cancer Center & Research Institute

Join to View Full Profile

12902 Magnolia DriveDepartment of Genitourinary OncologyTampa, FL 33612
Phone+1 813-745-8418
Fax+1 813-745-4675

Summary

Dr. Scott Gilbert is a Urologic Oncologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and Tampa General Hospital. He received his medical degree from Columbia University College of Physicians & Surgeons and has been in practice 17 years. He specializes in surgical oncology and is experienced in bladder cancer, testis cancer, RPLND, cystectomy and urinary diversion, including neobladder formation.

Education & Training

University of MichiganResidency, Urology, 2005 - 2008
University of Michigan School of Public HealthMS, Clinical Research Design and Statistical Analysis, 2005 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2001 - 2005
New York Presbyterian HospitalInternship, Transitional Year, 2000 - 2001
Columbia University Vagelos College of Physicians and SurgeonsClass of 2000
Brown UniversityBA, History of Art and Architecture, With Honors, 1992 - 1996

Certifications & Licensure

FL State Medical License 2008 - 2026
MI State Medical License 2005 - 2009
NY State Medical License 2005 - 2006
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Exemplary Teacher Award College of Medicine, University of Florida, 2011
Resident Teaching Award Department of Urology, University of Florida, 2011-2012
Outstanding Graduating Research Scholar American Urological Association Foundation, 2008
Wan Research Excellence Award Department of Urology, University of Michigan, 2007
Research Scholarship American Urological Association Foundation, 2007
ASCO Foundation Merit Award American Society of Clinical Oncology, Prostate Cancer Sympodium, San Francisco, CA, 2006
ASCO Foundation Merit Award American Society of Clinical Oncology, Annual Meeting, Atlanta, GA, 2006
Hope Foundation Fellow Scholarship Hope Foundation and Southwest Oncology Group, Urologic Oncology Section, 2006
AUA Gerald P Murphy Scholar, Outstanding Performance in Surgery American Urological Association, 2004
Peter Puchner Teaching Award, Resident Teacher of the Year Department of Urology, New York-Presbyterian Hospital, Columbia University Medical Center, 2004
Pfizer Scholars in Urology Award Department of Urology, New York-Presbyterian Hospital, Columbia University Medical Center, 2003
Humanism in Medicine Arnold P Gold Foundation
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Addressing Barriers to Palliative Care Use in Bladder Cancer Start of enrollment: 2020 Dec 22
Completed
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC Start of enrollment: 2020 Oct 26
ACTIVE_NOT_RECRUITING
PHASE1

Publications & Presentations

PubMed

Cisplatin-ineligible patients with muscle-invasive bladder cancer demonstrate poor long-term survival following immediate radical cystectomy.
Adnan Fazili, Seyed Behzad Jazayeri, Kyle M Rose, Christopher Guske, Lexiaochuan Wen
BJU International. 2025-09-11
Assessing the Impact of Treatment Timing Protocols in Clinical Trials for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer.
Christopher Guske, Seyed Behzad Jazayeri, Christian Harrs, Nagashree Rao, Facundo Davaro
European Urology Oncology. 2025-08-01
Comparing direct medical care costs of patients with bladder cancer who received an ileal conduit vs. neobladder in the year following cystectomy.
Matthew P Banegas, Maureen O'Keeffe Rosetti, Scott M Gilbert, Marilyn L Kwan, Michael C Leo
Urologic Oncology. 2025-04-01

Journal Articles

Designing for Impact: Identifying Stakeholder-Driven Interventions to Support Recovery After Major Cancer Surgery
Anobel Odisho, Ruth McMyn, Scot Gilbert, David Shibata, Supportive care in cancer

Books/Book Chapters

Prostate Cancer: A Comprehensive Perspectice
Chapter: Population-Based Outcomes Following Treatment of Clinically Localized Prostate Cancer.
Evans B, Gilbert SMEditors: Tewari A.Springer, London2013
Bladder Cancer: Diagnosis, Therapeutics and Management
Chapter: Continent Diversion: Quality of Life of Orthotopic Diversion vs. Ileal Conduit.
Gilbert SM, Lee CTEditors: Wood DP, Lee CT.Humana Press, New York, NYEdition Firs,2010
Complications of Urologic Surgery: Prevention and Management
Chapter: Complications Following Laparoscopic Robot-Assisted Radical Prostatectomy
Gilbert SM, Wood DPEditors: Taneja R.Saunders Elsevier, Philadelphia, PAEdition Four,2010
Chow’s Urology Oral Board Self-Assessment
Chapter: Kidney Cancer.
Gilbert SM, Hafez KEditors: Dahm P.Anadem Publishing, Columbus, OHEdition Thir,2010
Prostate Biopsy: Indications, Techniques and Complications
Chapter: Management and Controversies of High-Grade Prostatic Intraepithelial Neoplasia and Atypical Small Acinar Proliferation on Prostate Biopsy.
Weizer AZ, Gilbert SM, Shah RB and Wood DPEditors: Jones JS.Humana Press, Totowa, NJ2008
Campbell-Walsh Urology
Chapter: Laparoscopic and Robotic-Assisted Radical Prostatectomy and Pelvic Lymphadenectomy.
Su, LM, Gilbert SM, Smith JA JrEditors: Wein AJ, Partin AW, Peters CA, Kavoussi LR.Saunders/Elsevier PublishingEdition 11th,
Join now to see all

Abstracts/Posters

Variation in the potential over-treatment of prostate cancer in Florida. Poster Presentation (Awarded Best Poster of Session)
Gilbert SM, American Urological Association, Annual Meeting, San Diego, CA, 4/1/2013
Variation in over-treatment of prostate cancer in Florida. Poster Presentation
Gilbert SM, University of Florida & Shands Cancer Center Research Poster Day, 4/1/2013
Geographic and market variation in the potential over-treatment of prostate cancer in Florida. Poster Presentation
Gilbert SM, Genitourinary Cancer Symposium, ASCO, Annual Meeting, Orlando, FL, 2/1/2013
Quality of life and satisfaction among prostate cancer patients followed through a disease-specific survivorship clinic. Podium Presentation
Gilbert SM, International Society of Quality of Life, Annual Meeting, Budapest, Hungary, 10/1/2012
Functional outcomes, health-related quality of life and downstream complication among bladder cancer survivors. Podium Presentation
Gilbert SM, American Urological Association Foundation, Research Forum, San Francisco, CA, 5/1/2010
Downstream consequences of urinary diversion. Podium Presentation
Gilbert SM, American Urological Association, Annual Meeting, San Francisco, CA, 5/1/2010
Real-time health-related quality of life assessment among prostate cancer survivors. Poster Presentation
Gilbert SM, American Urological Association, Annual Meeting, Chicago, IL, 4/1/2009
Assessing patient centered survivorship care in prostate cancer. Podium Presentation
Gilbert SM, American Urological Association Foundation Scholar’s Breakfast, American Urological Association, Annual Meeting, Orlando, FL, 5/1/2008
Functional outcomes and recovery following seminal vesicle-sparing and nerve-sparing prostatectomy. Poster Presentation
Gilbert SM, Society of Urologic Oncology, Annual Meeting, Bethesda, MD, 12/1/2007
Increasing incidence and improved survival in testis cancer in the United States: a population-based appraisal. Podium Presentation
Gilbert SM, American Urological Association, Annual Meeting, Anaheim, CA, 5/1/2007
Using prolonged hospitalization as a proxy for quality in administrative data. Podium Presentation
Gilbert SM, American Urological Association, Annual Meeting, Anaheim, CA, 5/1/2007
Refining the focus of the volume-outcome relationship for urologic malignancies: The importance of non-index case volume. Poster Presentation
Gilbert SM, Society of Urologic Oncology, Annual Meeting, Bethesda, MD, 12/1/2006
Providing practitioner-specific outcomes is associated with higher patient satisfaction with information about prostate cancer treatment. Poster Presentation
Gilbert SM, American Society of Clinical Oncology, Annual Meeting, Atlanta, GA, 6/1/2006
Measuring Health-Related Quality of Life Outcomes in Bladder Cancer Patients Using the Newly Validated Bladder Cancer Index (BCI). Poster Presentation
Gilbert SM, American Urological Association, Annual Meeting, Atlanta, GA, 5/1/2006
Prostate Cancer Incidence and Mortality: Forecasted Trends in the Post-PSA Era. Poster Presentation
Gilbert SM, American Urological Association, Annual Meeting, Atlanta, GA, 5/1/2006
Attenuation of the Birth Cohort Effect in Testis Cancer. Poster Presentation
Gilbert SM, American Urological Association, Annual Meeting, Atlanta, GA, 5/1/2006
Prostate cancer incidence and mortality: Forecasting trends in the post-PSA period. Poster Presentation
Gilbert SM, Prostate Cancer Symposium, Orlando, FL, 2/1/2006
Providing practitioner-specific outcomes is associated with higher patient satisfaction with information about prostate cancer treatment. Poster Presentation
Gilbert SM, Prostate Cancer Symposium, San Francisco, CA, 2/1/2006
Measuring health-related quality of life in bladder cancer patients using the newly developed and validate Bladder Cancer Index (BCI). Podium Presentation
Gilbert SM, Society of Urologic Oncology, Annual Meeting, Bethesda, MD, 12/1/2005
Total number of lymph node removed, number of positive nodes, and lymph node density do not correlate with recurrence or survival in node-positive bladder cancer. Podi...
Gilbert SM, American Urologic Association, Annual Meeting, San Antonio, TX, 5/1/2005
Is partial nephrectomy a feasible option for multiple ipsilateral renal cortical tumors? Poster Presentation
Gilbert SM, American Urologic Association, Annual Meeting, San Antonio, TX, 5/1/2005
Re-evaluation of the TNM staging of conventional renal cortical tumors: outcomes of T1N0M0 and T3aN0M0 renal cortical tumors are equivalent. Poster Presentation
Gilbert SM, American Urologic Association, Annual Meeting, San Antonio, TX, 5/1/2005
Re-evaluation of the TNM staging classification of locally advanced renal cortical tumors; absolute size (T2) is more significant than renal capsular invasion (T3a). P...
Gilbert SM, American Urologic Association, Annual Meeting, San Francisco, CA, 5/1/2004
MN/CA9 expression predicts disease free survival in renal cell carcinoma. Poster Presentation
Gilbert SM, American Society of Clinical Oncology, Annual Meeting, Chicago, IL, 6/1/2003
Expression of the renal cell carcinoma specific gene MN/CA9 predicts disease free survival in patients undergoing radical nephrectomy for renal cortical tumors. Poster...
Gilbert SM, American Urologic Association, Annual Meeting, Chicago, IL, 4/1/2003
Join now to see all